Ga naar inhoud
Borski Fund 2 min lezen

Borski Fund makes new femtech investment

1 June 2022
May 31, 2022

Borski Fund, together with DSM Venturing, Calm/Storm Ventures, and three angel investors, has invested $10 million in inne. With this investment, inne will expand its hormone technology: from fertility to perimenopause.

Inne offers women more insight into hormone levels and thus into their health and fertility. Thousands of women across Europe use inne’s minilab, which measures progesterone levels with a saliva biosensor.

Perimenopause
Inne is now expanding its progesterone tracking function to perimenopause through an exclusive US partnership with Phenology, the new women’s health brand from the Hologram Sciences team. Women will soon be able to use the minilab to track hormonal changes during perimenopause—the early stage of menopause when hormone levels begin to decline. This is the first time this has been possible with a personalized home testing device.

Great femtech investment
Fund Director Simone Brummelhuis: ‘We are delighted to invest in inne and its exceptional team led by Eirini Rapti. The product is best-in-class for at-home hormone level testing. In a short time, inne has proven to be a leader in quantified self-solutions for women. We are excited about the many potential uses, from fertility to contraception and perimenopause. At Borski Fund, we invest in femtech and AI solutions because they offer enormous opportunities for all women.’

Testing stress levels
In addition to the expansion into perimenopause, inne will also add the ability to analyze stress with a dedicated cortisol tracking strip. Persistently high cortisol levels lead to a decrease in estrogen levels, which can result in weight gain, night sweats, sleep problems, and mood swings. By tracking cortisol levels, women can adjust their lifestyle to improve their long-term health. This can be particularly useful when trying to conceive or when managing symptoms of perimenopause.

About inne
Eirini Rapti founded inne in 2017 to provide women with technology that allows them to gain insight into their body’s hormonal levels. With inne’s biosensor minilab, women can measure their daily progesterone levels with a daily saliva test. Saliva measurement with the minilab has been proven to be as accurate as a laboratory progesterone test. Inne is currently in the process of being certified as an official contraceptive.

← Terug naar overzicht